Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $6,100 | 3 | 67.5% |
| Food and Beverage | $2,062 | 33 | 22.8% |
| Travel and Lodging | $868.82 | 7 | 9.6% |
| Education | $6.02 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $7,113 | 18 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $578.35 | 8 | $0 (2020) |
| PFIZER INC. | $431.25 | 5 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $315.45 | 3 | $0 (2021) |
| Novo Nordisk Inc | $297.78 | 4 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $114.45 | 1 | $0 (2018) |
| Teva Pharmaceuticals USA, Inc. | $73.94 | 1 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $66.01 | 1 | $0 (2017) |
| Circassia Pharmaceuticals Inc | $17.74 | 1 | $0 (2018) |
| Theravance Biopharma Inc. | $15.16 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $73.60 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($73.60) |
| 2020 | $151.15 | 3 | AstraZeneca Pharmaceuticals LP ($151.15) |
| 2019 | $198.39 | 2 | AstraZeneca Pharmaceuticals LP ($124.45) |
| 2018 | $776.87 | 11 | AstraZeneca Pharmaceuticals LP ($302.75) |
| 2017 | $7,837 | 27 | Janssen Pharmaceuticals, Inc ($7,113) |
All Payment Transactions
44 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/23/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $73.60 | General |
| Category: DIABETES | ||||||
| 11/19/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $77.83 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/06/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $6.98 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/28/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $66.34 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/05/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $124.45 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/07/2019 | Teva Pharmaceuticals USA, Inc. | AJOVY (Drug) | Food and Beverage | In-kind items and services | $73.94 | General |
| Category: Central Nervous System | ||||||
| 12/06/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $114.29 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/02/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $114.45 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/22/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/20/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $91.93 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/19/2018 | PFIZER INC. | LYRICA (Drug) | Food and Beverage | In-kind items and services | $103.67 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 08/29/2018 | Circassia Pharmaceuticals Inc | TUDORZA PRESSAIR (Drug), NIOX VERO | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: PULMONARYRESPIRATORY DISEASES | ||||||
| 05/22/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $124.00 | General |
| Category: Diabetes | ||||||
| 04/11/2018 | PFIZER INC. | LYRICA (Drug) | Food and Beverage | In-kind items and services | $6.54 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 02/28/2018 | PFIZER INC. | LYRICA (Drug) | Food and Beverage | In-kind items and services | $94.19 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 02/01/2018 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Food and Beverage | In-kind items and services | $82.22 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/05/2018 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: RESPIRATORY | ||||||
| 09/21/2017 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $121.50 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/14/2017 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $66.01 | General |
| Category: DIABETES | ||||||
| 09/11/2017 | Janssen Pharmaceuticals, Inc | — | Education | In-kind items and services | $6.02 | General |
| 08/29/2017 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $84.27 | General |
| Category: Diabetes | ||||||
| 05/11/2017 | PFIZER INC. | LYRICA (Drug) | Food and Beverage | In-kind items and services | $105.35 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 04/25/2017 | Theravance Biopharma Inc. | VIBATIV (Drug) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: Infectious Disease | ||||||
| 03/21/2017 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $76.15 | General |
| Category: Diabetes | ||||||
| 03/02/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Travel and Lodging | Cash or cash equivalent | $117.70 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 13 | 16 | $2,000 | $339.48 |
| 2022 | 14 | 470 | 1,123 | $70,830 | $25,485 |
| 2021 | 17 | 671 | 1,978 | $129,422 | $51,732 |
| 2020 | 20 | 845 | 2,361 | $145,775 | $50,336 |
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 13 | 16 | $2,000 | $339.48 | 17.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 67 | 204 | $25,500 | $15,331 | 60.1% |
| 99307 | Follow-up nursing facility visit per day, typically 10 minutes | Office | 2022 | 42 | 159 | $12,720 | $2,902 | 22.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 18 | 18 | $2,945 | $1,648 | 55.9% |
| 71045 | X-ray of chest, 1 view | Office | 2022 | 52 | 90 | $6,750 | $1,247 | 18.5% |
| 70210 | X-ray of paranasal sinus, 1-2 views | Office | 2022 | 31 | 65 | $5,200 | $1,060 | 20.4% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 30 | 46 | $2,760 | $725.46 | 26.3% |
| 92567 | Test to assess middle ear function | Office | 2022 | 28 | 60 | $2,100 | $592.00 | 28.2% |
| 82947 | Blood glucose (sugar) level | Office | 2022 | 50 | 117 | $2,925 | $443.98 | 15.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 51 | 117 | $1,755 | $337.99 | 19.3% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2022 | 13 | 15 | $1,275 | $329.62 | 25.9% |
| 74018 | X-ray of abdomen, 1 view | Office | 2022 | 12 | 19 | $1,425 | $326.77 | 22.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 17 | 32 | $1,120 | $279.05 | 24.9% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2022 | 42 | 69 | $3,795 | $253.55 | 6.7% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 17 | 112 | $560.00 | $8.91 | 1.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 105 | 354 | $44,250 | $28,336 | 64.0% |
| 99307 | Subsequent nursing facility visit, typically 10 minutes per day | Office | 2021 | 43 | 393 | $31,510 | $11,180 | 35.5% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2021 | 53 | 123 | $7,380 | $2,327 | 31.5% |
| 71045 | X-ray of chest, 1 view | Office | 2021 | 81 | 143 | $10,725 | $1,887 | 17.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 17 | 17 | $2,760 | $1,688 | 61.2% |
| 70210 | X-ray of paranasal sinus, less than 3 views | Office | 2021 | 34 | 91 | $7,280 | $1,618 | 22.2% |
| 92567 | Eardrum testing using ear probe | Office | 2021 | 30 | 91 | $3,185 | $1,002 | 31.5% |
| 82947 | Blood glucose (sugar) level | Office | 2021 | 63 | 179 | $4,475 | $665.87 | 14.9% |
| 74018 | X-ray of abdomen, 1 view | Office | 2021 | 21 | 35 | $2,625 | $605.59 | 23.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 66 | 181 | $2,750 | $513.20 | 18.7% |
About Dr. Scott Nelson, MD
Dr. Scott Nelson, MD is a Family Medicine healthcare provider based in Cleveland, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1336220276.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Nelson, MD has received a total of $9,037 in payments from pharmaceutical and medical device companies, with $73.60 received in 2021. These payments were reported across 44 transactions from 11 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($6,100).
As a Medicare-enrolled provider, Nelson has provided services to 1,999 Medicare beneficiaries, totaling 5,478 services with total Medicare billing of $127,892. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Cleveland, MS
- Active Since 10/18/2006
- Last Updated 07/08/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1336220276
Products in Payments
- INVOKANA (Drug) $7,107
- FARXIGA (Drug) $496.13
- LYRICA (Drug) $309.75
- JARDIANCE (Drug) $190.78
- Tresiba (Drug) $160.42
- PRADAXA (Drug) $124.67
- Ozempic (Drug) $124.00
- ELIQUIS (Drug) $121.50
- ENTRESTO (Drug) $114.45
- BYDUREON (Drug) $82.22
- AJOVY (Drug) $73.94
- TOUJEO (Drug) $66.01
- TUDORZA PRESSAIR (Drug) $17.74
- VIBATIV (Drug) $15.16
- BREO (Drug) $13.53
- Victoza (Drug) $13.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Cleveland
Dominic King, D.o, D.O
Family Medicine — Payments: $337,674
Jeannette Potts, Md, MD
Family Medicine — Payments: $30,044
Meaghan Combs, Md, MD
Family Medicine — Payments: $25,727
George Stokes, Md, MD
Family Medicine — Payments: $18,678
Dr. Charles Brock, M.d, M.D
Family Medicine — Payments: $9,519
Mr. Cecil Breetzke, Md, MD
Family Medicine — Payments: $9,499